Sharechat Logo

Exchange merger under scrutiny

By Chris Hutching

Friday 30th June 2000

Text too small?
Stock Exchange chairman Eion Edgar has confirmed a merger with the Australian Stock Exchange is still possible but says it may not be the solution to poor stock performance.

More details about the exchange's future options will be revealed when the annual report is issued next Monday. It will contain the findings of former board member Jon Cimino of Warburg Dillon Read. Mr Edgar said many commentators confused the exchange's performance with share prices. It was already a world leader in efficiency and settlement of transactions. But other structural differences made comparisons inappropriate.

These included the lack of a national savings scheme which underpins the markets in Singapore and Australia. New Zealand companies also paid dividends averaging 8% compared with 1% in the US where investors had higher expectations of share price rises.

Mr Edgar said Australian investors already had the ability to tap into kiwi stocks through dual listings but there was little evidence investors were rushing to buy into them.

There appeared to be no clear model of what would be most successful. Most of the international mergers occurred only in the past six months and it was too early to judge the effect. The key question remained - whether merging would benefit members, investors or companies, Mr Edgar said.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report